Prognostic factors in patients with advanced neuroendocrine neoplasia treated with radiopeptides (PRRT) - Data from the national registry SEPTRALU

被引：0
|
作者：
Bello, P. [1 ]
Mitjavila Casanovas, M. [2 ]
Jimenez-Fonseca, P. [3 ]
Cabezas Agricola, J. M. [4 ]
Hernando Cubero, J. [5 ]
Garcia Canamaque, L. [6 ]
Gajate, P. [7 ]
Riesco, M. C. [8 ]
Custodio, A. [1 ,9 ]
Miguel Martinez, M. B. [10 ]
Balaguer, D. [11 ]
Carmona-Bayonas, A. [12 ]
机构：
[1] Hosp Univ La Fe, Dept Nucl Med, Valencia, Spain
[2] Hosp Univ Puerta Hierro, Dept Nucl Med, Madrid, Spain
[3] Hosp Univ Cent Asturias, Dept Med Oncol, Oviedo, Spain
[4] Hosp Univ Santiago Compostela, Santiago De Compostela, Spain
[5] Hosp Univ Val dHebron, Barcelona, Spain
[6] Hosp HM Sanchinarro, Madrid, Spain
[7] Hosp Univ Ramon y Cajal, Madrid, Spain
[8] Hosp Univ Doce Octubre, Madrid, Spain
[9] Hosp Univ La Paz, Madrid, Spain
[10] Hosp Univ Burgos, Burgos, Spain
[11] Hosp Univ Doctor Peset, Valencia, Spain
[12] UMU, Hosp Univ Morales Meseguer, Hematol & Med Oncol Dept, IMIB, Murcia, Spain
来源：
JOURNAL OF NEUROENDOCRINOLOGY | 2023年 / 35卷
关键词：
177lu-dotatate; neuroendocrine tumor; prrt; prognosis; radionuclide therapy; survival;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
H05
引用
收藏
页码：177 / 177
页数：1
相关论文
共 50 条
  • [41] Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE)
    Garcia-Carbonero, R.
    Capdevila, J.
    Crespo-Herrero, G.
    Diaz-Perez, J. A.
    Martinez del Prado, M. P.
    Alonso Orduna, V.
    Sevilla-Garcia, I.
    Villabona-Artero, C.
    Beguiristain-Gomez, A.
    Llanos-Munoz, M.
    Marazuela, M.
    Alvarez-Escola, C.
    Castellano, D.
    Vilar, E.
    Jimenez-Fonseca, P.
    Teule, A.
    Sastre-Valera, J.
    Benavent-Vinuelas, M.
    Monleon, A.
    Salazar, R.
    ANNALS OF ONCOLOGY, 2010, 21 (09) : 1794 - 1803
  • [42] Lutetium177 in patients with stage IV neuroendocrine tumours of any origin. Data from 321 patients of the multicenter national registry
    Mitjavila Casanovas, M.
    Bello, P.
    Pubul, V.
    Garcia, A.
    Arbizu, J.
    Navarro, T.
    Marin, D.
    Castellon, M.
    Duran, C.
    Field, C.
    Llana, B.
    Miguel, B.
    Estorch, M.
    Hernando, J.
    Custodio, A.
    Repetto, A.
    Vercher-Conejero, J.
    Muros, A.
    Cano, J.
    Caballero, E.
    Garcia, P.
    Blanco, C.
    Aller, J.
    Carmona, A.
    Jimenez-Fonseca, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S333 - S334
  • [43] Pathological Prognostic Factors for Survival in Neuroendocrine Neoplasms of Esophagus: Results from the National Cancer Database
    Taherian, Mehran
    Samankan, Shabnam
    Groman, Adrienne
    Yendamuri, Sai
    Bhalla, Amarpreet
    LABORATORY INVESTIGATION, 2019, 99
  • [44] Prognostic effect of surgery of metastases in patients with advanced gastric cancer: Real-world data from the AGAMENON registry
    Jimenez-Fonseca, P.
    Hernandez, R.
    Custodio, A.
    Ramchandani Vaswani, A.
    Sanchez Canovas, M.
    Sanchez Bayona, R.
    Lopez Lopez, C.
    Echavarria Diaz-Guardamino, I.
    Visa, L.
    Buxo Orra, E.
    Arias, D.
    Viudez, A.
    Martin Carnicero, A.
    Cerda, P.
    Ferrer, M.
    Lorenzo Barreto, J. E.
    Limon, M. L.
    Macias, I.
    Felices, P.
    ANNALS OF ONCOLOGY, 2017, 28
  • [45] Pathological Prognostic Factors for Survival in Neuroendocrine Neoplasms of Esophagus: Results from the National Cancer Database
    Taherian, Mehran
    Samankan, Shabnam
    Groman, Adrienne
    Yendamuri, Sai
    Bhalla, Amarpreet
    MODERN PATHOLOGY, 2019, 32
  • [46] Prognostic factors of patients with advanced lung cancer treated with anlotinib: a retrospective cohort study
    Fan, Bijun
    Tan, Xiaoming
    Lou, Yueyan
    Zheng, Yu
    Zhang, Liyan
    Wu, Xueling
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2021, 49 (10)
  • [47] Prognostic factors in patients with locally advanced head and neck cancer treated with concurrent radiochemotherapy
    Franceschini, Davide
    Paiar, Fabiola
    Saieva, Calogero
    Bonomo, Pierluigi
    Agresti, Benedetta
    Meattini, Icro
    Greto, Daniela
    Mangoni, Monica
    Meacci, Fiammetta
    Loi, Mauro
    Zei, Giacomo
    Livi, Lorenzo
    Biti, Giampaolo
    RADIOLOGIA MEDICA, 2016, 121 (03): : 229 - 237
  • [48] Prognostic factors in patients with advanced hypopharyngeall squamous cell carcinoma treated with concurrent chemoradiotherapy
    Krstevska, V.
    Stojkovski, I.
    Zafirova-Ivanovska, B.
    Crvenkova, S.
    JOURNAL OF BUON, 2012, 17 (02): : 327 - 336
  • [49] Prognostic factors in patients with advanced unresectable biliary tract carcinoma treated by systemic chemotherapy
    Nakachi, Kohei
    Furuse, Junji
    Ishi, Hiroshi
    Yoshino, Masahiro
    ANNALS OF ONCOLOGY, 2004, 15 : 244 - 244
  • [50] The prognostic and predictive factors for patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy
    Acun, M.
    Alikanoglu, A.
    Onder, A.
    Ozturk, B.
    Alparslan, A.
    Karaca, M.
    ANNALS OF ONCOLOGY, 2021, 32 : S196 - S196
12345